STAT3 and cancer: Overall, this pathway seems to be of interest in cancer treatment, as it has been shown that patients of several cancer types, such as lung and prostate cancers, have a worse outcome when STAT3 and 5 are activated, while STAT1 activation is generally associated with better prognosis [40].